Insulin Degludec/Liraglutide Noninferior to Insulin Glargine

This article originally appeared here.
Share this content:
Insulin Degludec/Liraglutide Noninferior to Insulin Glargine
Insulin Degludec/Liraglutide Noninferior to Insulin Glargine

WEDNESDAY, March 2, 2016 (HealthDay News) -- For patients with uncontrolled type 2 diabetes, a fixed ratio of insulin degludec/liraglutide is noninferior to continued titration of insulin glargine, according to a study published in the March 1 issue of the Journal of the American Medical Association.

Ildiko Lingvay, M.D., M.P.H., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a phase 3, 26-week trial at 76 centers in 10 countries involving 557 patients with uncontrolled diabetes. Participants were treated with glargine and metformin and had glycated hemoglobin (HbA1c) levels of 7 to 10 percent. They were randomly allocated to degludec/liraglutide (278 patients) or glargine (279 patients), with twice-weekly titration to a glucose target of 72 to 90 mg/dL

The researchers found that the HbA1c level reduction was greater with degludec/liraglutide than glargine (−1.81 percent versus −1.13 percent), meeting the criteria for noninferiority and superiority (both P < 0.001). Compared with glargine, treatment with degludec/liraglutide correlated with weight loss (versus weight gain) and fewer confirmed hypoglycemic episodes. The groups had similar rates of overall and serious adverse events, although more nonserious gastrointestinal adverse events were reported with degludec/liraglutide.

"Treatment with degludec/liraglutide compared with up-titration of glargine resulted in noninferior HbA1c levels, with secondary analyses indicating greater HbA1c level reduction after 26 weeks of treatment," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC: Too Many Health Care Workers Not Getting Flu Vaccine

CDC: Too Many Health Care Workers Not Getting ...

Vaccination protects both workers and patients

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Patients discharged sooner, become more functional when they leave the hospital

is free, fast, and customized just for you!

Already a member?

Sign In Now »